Addiction News and Research

RSS
Study demonstrates cost-effectiveness of Ottawa Model for Smoking Cessation

Study demonstrates cost-effectiveness of Ottawa Model for Smoking Cessation

Alkermes reports data from aripiprazole lauroxil phase 3 clinical trial for treatment of schizophrenia

Alkermes reports data from aripiprazole lauroxil phase 3 clinical trial for treatment of schizophrenia

Brain iron levels offer potential biomarker in the diagnosis of ADHD

Brain iron levels offer potential biomarker in the diagnosis of ADHD

Researchers explore role of stem cells in treating neuroinjury and neurodegenerative disorders

Researchers explore role of stem cells in treating neuroinjury and neurodegenerative disorders

Combining 2 smoking cessation therapies more effective for highly nicotine-dependent smokers

Combining 2 smoking cessation therapies more effective for highly nicotine-dependent smokers

Research finds food addicts lacking psychological inhibition

Research finds food addicts lacking psychological inhibition

Recover programs are expensive and hard to find for addicted teens

Recover programs are expensive and hard to find for addicted teens

Mass. to spend $20 million to combat opioid use

Mass. to spend $20 million to combat opioid use

8.5 million on Medicare get opioids

8.5 million on Medicare get opioids

First Edition: June 11, 2014

First Edition: June 11, 2014

New prescription weight-loss medication combines antidepressant with addiction medication

New prescription weight-loss medication combines antidepressant with addiction medication

RBCC's injectable technology poised to improve use of addiction treatment drug

RBCC's injectable technology poised to improve use of addiction treatment drug

Helix Healthcare Group offers individualized treatment for substance abuse, addiction, mental health issues

Helix Healthcare Group offers individualized treatment for substance abuse, addiction, mental health issues

Alkermes initiates FORWARD-3 and FORWARD-4 efficacy studies in pivotal clinical program for ALKS 5461

Alkermes initiates FORWARD-3 and FORWARD-4 efficacy studies in pivotal clinical program for ALKS 5461

New therapeutic interventions could render addiction into manageable disease

New therapeutic interventions could render addiction into manageable disease

School prevention program can dramatically cut teen cigarette smoking in Italy

School prevention program can dramatically cut teen cigarette smoking in Italy

NIDA review offers new insights into the negative health effects of marijuana

NIDA review offers new insights into the negative health effects of marijuana

BioDelivery Sciences receives approval of NDA for BUNAVAIL from FDA

BioDelivery Sciences receives approval of NDA for BUNAVAIL from FDA

Many heroin users transitioned from prescription opioids, finds study

Many heroin users transitioned from prescription opioids, finds study

Study calls for more randomized trials on e-cigarettes

Study calls for more randomized trials on e-cigarettes

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.